Objective-Enzyme-modified nonoxidized low-density lipoprotein (ELDL) is present in human atherosclerotic lesions. Our objective is to understand the mechanisms of ELDL uptake and its effects on vascular smooth muscle cells (SMC). Approach and Results-Transformation of murine aortic SMCs into foam cells in response to ELDL was analyzed. ELDL, but not acetylated or oxidized LDL, was potent in inducing SMC foam cell formation. Inhibitors of macropinocytosis (LY294002, wortmannin, amiloride) attenuated ELDL uptake. In contrast, inhibitors of receptor-mediated endocytosis (dynasore, sucrose) and inhibitor of caveolae-/lipid raft-mediated endocytosis (filipin) had no effect on ELDL uptake in SMC, suggesting that macropinocytosis is the main mechanism of ELDL uptake by SMC. Receptor for advanced glycation end products (RAGE) is not obligatory for ELDL-induced SMC foam cell formation, but primes SMC for the uptake of oxidized LDL in a RAGE-dependent manner. ELDL increased intracellular reactive oxygen species, cytosolic calcium, and expression of lectin-like oxidized LDL receptor-1 in wild-type SMC but not in RAGE −/− SMC. The macropinocytotic uptake of ELDL is regulated predominantly by intracellular calcium because ELDL uptake was completely inhibited by pretreatment with the calcium channel inhibitor lacidipine in wild-type and RAGE −/− SMC. This is in contrast to pretreatment with PI3 kinase inhibitors which completely prevented ELDL uptake in RAGE −/− SMC, but only partially in wild-type SMC. Conclusions-ELDL is highly potent in inducing foam cells in murine SMC. ELDL endocytosis is mediated by calciumdependent macropinocytosis. Priming SMC with ELDL enhances the uptake of oxidized LDL. (Arterioscler Thromb The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
F oam cell formation is the central feature in the initiation and development of atherosclerotic lesions. Because foam cells express several macrophage markers, it is thought that foam cells arise primarily from monocyte-derived macrophages. Despite the understandable emphasis on macrophage foam cells, there is evidence for the participation also of smooth muscle cells (SMCs) in forming foam cells. This is particularly relevant in human arteries which are enriched in SMC. [1] [2] [3] Scavenger receptors account for lipid accumulation in macrophages primarily through uptake of modified low-density lipoproteins (LDLs), such as oxidized LDL (OxLDL). 4, 5 SMCs also express scavenger receptors 6, 7 and acquire macrophage-like phenotypes on lipid loading, expressing macrophage markers, and suppression of SMC markers. 8 SMC-derived foam cells in human atherosclerotic lesions are well documented, [9] [10] [11] [12] with recent studies showing as many as 50% of foam cells in human and murine lesions as may be SMC derived. 10, 13 The characteristics of SMC-derived foam cells are less well established. Recent studies have suggested that there are significant distinctions in gene expression and modes of lipid loading between macrophages and SMC. For example, lipidloaded macrophages express high levels of cholesterol transporter ABCA1, 14 scavenger receptors CD36 and SRA1 15, 16 and undergo apoptosis on excess free cholesterol loading. 17 In contrast, SMC-derived foam cells express significantly less ABCA1 9, 10 and are apparently more resistant to free cholesterol toxicity. 18 Studies in vitro have shown lipid loading of SMC by cholesterol, 8 OxLDL, 19 and enzyme-modified nonoxidized LDL (ELDL), 20 but mechanisms by which SMC take up lipids in vivo are mostly unknown.
ELDL differs from OxLDL in that it lacks oxidized lipids. 21 ELDL has been detected in human atherosclerotic lesions and has been generated in vitro by the joint action of trypsin and cholesteryl ester hydrolase. [21] [22] [23] [24] Although cholesteryl ester hydrolase is present in the human atherosclerotic vessels at concentrations high enough for direct detection by immunostaining, 25, 26 there are many protease candidates that could act on vessel wall LDL in vivo. Chymase, plasmin, matrix metalloproteinases, and cathepsins are highly expressed in atherosclerotic plaques, 24, [26] [27] [28] [29] [30] [31] [32] and potentially could act on LDL as modifying proteases. Plasmin and matrix metalloproteinases were reported to colocalize with ELDL in human atherosclerotic lesions. 29 Here, we report that ELDL uptake by SMC occurs via macropinocytosis rather than by scavenger receptor-dependent mechanisms. Interestingly, we found that lectin-like oxidized LDL receptor (LOX-1), a major scavenger receptor for OxLDL, 33, 34 is significantly upregulated by ELDL in SMC and this upregulation is dependent on the receptor for advanced glycation end products (RAGE).
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. In brief, ELDL was prepared from native LDL on digestion with trypsin and cholesterol esterase followed by dialysis and sterile filtration which resulted in ELDL particle size between 100 and 2500 KD.
Results

ELDL, But Not Acetylated LDL or OxLDL, Induces Foam Cells in Mouse Aortic SMCs In Vitro
ELDL has been shown to be a more efficient inducer of macrophage foam cells than are other modified LDLs, such as acetylated LDL (AcLDL) or OxLDL. 21 Nevertheless, the comparative ability of these modified LDLs to induce foam cell formation in SMC has not been studied. Therefore, SMC and macrophages were cultured in the presence of 10 μg/mL of a modified LDL (AcLDL, OxLDL, or ELDL) and lipid content was visualized by staining with Oil Red O. The accumulation of lipid was evident as early as 4 hours after incubation with modified LDLs. As expected, ELDL, OxLDL, and AcLDL at 10 μg/mL induced significant foam cell formation in macrophages during 24 hours in contrast to SMC, where only ELDL induced foam cells ( Figure 1A ). This was confirmed by quantitative assessment of cellular cholesterol accumulation ( Figure 1B ). ELDL at 10, 25, and 50 μg/mL induced dosedependent accumulation of lipid in SMC ( Figure 1C and 1D). Although at 100 μg/mL, significant foam cell formation was observed, cell viability was <50%, probably because of cholesterol toxicity (data not shown). Substantially higher concentrations were required for SMC foam cell formation by AcLDL (500 μg/mL) and OxLDL (200 μg/mL) as shown in Figure 1C and 1D. The small amount of intracellular lipid accumulation induced by AcLDL (500 μg/mL) was associated with significant amount of cell death as evidenced by trypan blue staining (≈75%, data not shown). Increased cell death was also observed in SMC treated with OxLDL at concentrations >200 μg/mL perhaps because of the presence of modified sterols in these LDLs (data not shown). Previously it has been shown that the concentration of LDL in the intimal fluid of normal and atherosclerotic lesions is 2 to 4 times higher than that in circulation. 35 Because the normal concentration of LDL in circulation is ≈1 mg/mL, the concentration of LDL in the intimal fluid may be at least 2 mg/mL. We found that native LDL when used at 2 mg/mL induced foam cells in SMC even though it was significantly less than that by ELDL at 10 μg/mL ( Figure 1C and 1D).
As we aimed to quantify the uptake of modified LDLs by SMC as whole particles, we normalized loading of cells with LDL, ELDL, AcLDL, and OxLDL based on lipoprotein protein rather than cholesterol, because modified LDL uptake by cells is often a protein (receptor)-based phenomenon. As shown in Figure IA in the online-only Data Supplement, the cholesterol to protein ratio differs among these modified lipoproteins. Nevertheless, the experiments shown in Figure 1C and 1D, even when recalculated on the basis of lipoprotein cholesterol exposure, showed that ELDL was much more effective in SMC lipid loading than any of the other 3 tested lipoprotein preparations ( Figure IB in the online-only Data Supplement). LDL receptor mediates the uptake of modest amounts of native LDL with the consequent modification of the regulatory pool of sterol which tightly regulates LDL receptor mRNA expression. 36 We measured LDL receptor mRNA expression in SMC incubated with native or modified LDLs at 10 μg protein/mL. LDL receptor mRNA was downregulated in LDL-and ELDL-loaded SMCs (≈ 25% and 75% decrease, respectively) compared with bovine serum albumin-treated SMC, whereas AcLDL or OxLDL showed no such effect ( Figure II in the online-only Data Supplement). By this measure too, ELDL delivered much more cholesterol to the sterol regulatory pool of SMC than did AcLDL or OxLDL at an experimental concentration of 10 μg/mL.
Aortic SMCs Endocytose the Larger LDL Particles in ELDL Preparations
Particle size of native LDL is ≈25 nm, whereas ELDL preparations were shown to contain a heterogeneous mixture of particles with sizes ranging from 10 to 200 nm. 21 Enzyme action results in the fusion of many LDL particles forming larger particles in ELDL preparations. 21 This was confirmed by us in agarose gel electrophoresis of native LDL versus modified LDLs. ELDL had a lower electrophoretic mobility than native LDL indicating a higher mass or less negative charge for ELDL ( Figure 2A ). In addition, we found that tryptic proteolysis without cholesterol esterase induced a similar pattern of lower electrophoretic mobility. In contrast, exposure to cholesterol esterase alone did not result in slower moving particles. As expected, OxLDL and AcLDL showed higher electrophoretic mobility than native LDL. 37 Taken together, tryptic proteolysis of LDL alters electrophoretic mobility of LDL particles, likely reflecting changes in mass and charge. In accordance with earlier reports, 21 we found SMC foam cell formation by ELDL modified by trypsin or cholesterol esterase alone was much less efficient than SMC foam cell formation with ELDL modified by both trypsin and cholesterol esterase (data not shown).
Nonstandard Abbreviations and Acronyms
Aiming to identify the components in ELDL preparations that were responsible for foam cell formation in SMC, we used fast protein liquid chromatography to separate ELDL particles according to particle sizes. ELDL showed 2 protein peaks; 1 peak corresponding to the fast protein liquid chromatography elution profile of human plasma very LDL, and another peak corresponding to that of human plasma LDL ( Figure 2B , upper panel). Even though both peaks contained proteins, only the fractions in the first peak (very LDL-sized peak) contained cholesterol and phospholipid. The second peak representing smaller proteins did not have any measurable amount of cholesterol and contained a small amount of phospholipid ( Figure 2B , lower panels). ELDL preparations also seem to contain phospholipid-containing vesicles that are apparently devoid of protein as noted in fractions 14 and 16 in Figure 2B . Importantly, when fast protein liquid chromatography fractions from both peaks were incubated with wild-type (WT) aortic SMC, only the larger size fractions (fractions 8-10) induced foam cell formation ( Figure 2C and quantified in Figure 2D ).
Taken together, this indicates that the larger particles within ELDL preparations were responsible for foam cell formation in mouse aortic SMC. However, it is not clear whether the activity of the large particles is attributable to its much higher cholesterol content or whether particle size per se also played a role.
RAGE-Dependent Upregulation of OxLDL Receptor-1 (LOX-1) Expression by ELDL in Aortic SMC
Scavenger receptor-dependent endocytosis is the principle route for modified LDL uptake by cells, with CD36, SRA1, and LOX-1 as the major scavenger receptors involved in this process. 38 ELDL uptake in macrophages has been suggested to be partly through CD36, 21, 23 whereas the mechanisms of ELDL uptake in vascular SMC is currently unknown. We measured mRNA expression of CD36, SRA1, and LOX-1 in mouse aortic SMC in response to incubation with ELDL, AcLDL, and OxLDL using real-time reverse transcription polymerase chain reaction. In contrast to the known upregulation of CD36 and SRA1 expression in macrophages on lipid loading, 38 we found no change in CD36 and SRA1 mRNA in SMC on incubation with the modified LDLs Figure 3A) . Interestingly, mRNA for the receptor for oxidized LDL (LOX-1), a major scavenger receptor in arterial cells, 39 was increased ≈ 4-fold in SMC on incubation with ELDL (P<0.01), and to a lesser extent (≈20%, P<0.05) on incubation with OxLDL ( Figure 3A ). Protein levels of LOX-1 were also increased significantly in SMC on incubation with ELDL, but did not change in response to native LDL, AcLDL, or OxLDL ( Figure 3B ). Native LDL even at 2 mg/mL did not show any changes in LOX-1 mRNA or protein in the SMC (data not shown).
Oligomerization of ligands is known to enhance ligand binding and activation of RAGE. 40 Because our data suggests that ELDL consists of aggregated or fused LDL molecules as shown in Figure 2A , we queried whether RAGE might play a role in the upregulation of LOX-1 by ELDL. We used aortic SMC isolated from RAGE-deficient mice (RAGE −/− SMC) and from mice with intact RAGE signaling (WT SMC). LOX-1 protein was dose dependently upregulated in WT SMC incubated for 24 hours with ≤25 μg/mL ELDL, whereas higher concentrations of ELDL (50 μg/mL) showed a decrease in LOX-1 protein expression ( Figure 3C ). On the other hand, surprisingly, we found ELDL did not upregulate LOX-1 protein or mRNA expression in RAGE −/− SMC ( Figure 3C and 3D). OxLDL is known to bind RAGE on account of its advanced glycation endproducts (AGE) epitopes. 41 Although ELDL to date has not been described as a RAGE-binding molecule, it is possible that ELDL too has AGE-like epitopes that could mediate binding to RAGE. However, binding of ELDL to RAGE is indirectly suggested by our experiments as shown in Figure III in the online-only Data Supplement. When SMC were incubated with recombinant human RAGE or with recombinant human RAGE precomplexed with ELDL (hRAGE/ELDL), hRAGE was immunodetected only in the lysates of cells incubated with hRAGE (lane 2), and not in the lysates of cells incubated with the hRAGE/ELDL complex (lane 4). This suggests that hRAGE may be binding to integrins, collagens, and other cell membrane structures as previously described. 42 The inability to detect hRAGE when cells were incubated with hRAGE/ELDL complexes is possibly related to a rapid uptake of the complexes into the cytosol and subsequent lysosomal/ proteolytic degradation of hRAGE. If this were the case, it implies that hRAGE is carried into the cells by ELDL, ie, that the 2 molecules do form a bimolecular complex. Alternatively, the preformed complexes may obstruct the association of hRAGE with the cells and be washed away before preparation of the SMC lysate. At present, we cannot distinguish between these possibilities, nevertheless, these observations indirectly suggest that ELDL binds RAGE. Taken together, ELDL upregulates LOX-1 in aortic SMC in a RAGE-dependent manner; however, the details of this interaction and whether ELDL binds directly to RAGE requires future investigation. It is also unknown at this point whether LOX-1 upregulation is dependent on any cytoplasmic component in ELDL-RAGE signaling.
OxLDL uptake by SMC is low as shown in Figure 1 . However, given the ability of ELDL to induce LOX-1 mRNA and protein in SMC, we next examined whether preincubation with ELDL would increase uptake of OxLDL by the SMC. We preincubated WT and RAGE −/− SMC with ELDL (10 μg/mL) for 24 hours followed by incubation with 10 μg/mL DiI-labeled OxLDL or DiI-labeled native LDL (as control) for 24 hours. ELDL was removed before adding DiI-labeled lipoproteins. We found that in WT SMC, ELDL significantly increased uptake of DiI-labeled OxLDL but not the uptake of DiI-LDL ( Figure 3E and quantified in Figure 3F ). However, in RAGE −/− SMC, pretreatment with ELDL did not promote the uptake of DiI-OxLDL. This suggests, at least in culture, that ELDL in a RAGE-dependent manner primes SMC for enhanced uptake of OxLDL possibly via upregulation of LOX-1. However, despite these findings suggesting a role for RAGE in facilitating uptake of OxLDL, RAGE is not required for ELDL-induced SMC foam cell formation because robust lipid accumulation was seen in RAGE −/− SMC on incubation with ELDL ( Figure 3G and 3H). In other words, the loading of SMC with cholesterol derived from ELDL can occur independent of RAGE, but upregulation of LOX-1 receptor and its promotion of OxLDL uptake are regulated via RAGE.
ELDL Endocytosis by Aortic SMCs Is Not Receptor/Clathrin Mediated or Lipid Raft/Caveolae Dependent, But Mediated by Macropinocytosis
Aiming to identify the route of ELDL endocytosis in murine aortic SMC, we focused on the 3 major endocytic pathways that have been studied extensively, 43 namely the receptor-mediated In receptor-mediated endocytosis, the separation of the budding clathrin-coated vesicle from plasma membrane relies on the guanosine triphosphatase, dynamin. 44 Dynasore, a pharmacological inhibitor of dynamin, is known to completely block receptor-mediated endocytosis. 44 However, as shown in Figure 4A , dynasore (100 μmol/L) did not inhibit ELDL-induced foam cell formation in aortic SMC as shown by Oil Red O staining ( Figure 4A and quantified in Figure 4D ). Similarly, SMC cultured in hypertonic media containing 0.1 mol/L sucrose, a known inhibitor of receptor-mediated endocytosis, 43 showed intact foam cell formation in response to treatment with ELDL ( Figure 4A and quantified in Figure 4D ). As expected, treatment of SMC with dynasore (100 μmol/L) or sucrose (0.1 mol/L) attenuated the uptake of transferrin, a classical ligand for receptor-mediated endocytosis 43 ( Figure IV in the online-only Data Supplement). Two potential candidate receptors for uptake of ELDL by SMC could be LOX-1 and RAGE. However neither seems to be directly involved in the uptake of ELDL, because antibody specific to LOX-1 did not attenuate ELDL uptake and foam cell formation in SMC ( Figure V in the online-only Data Supplement). Moreover, SMC lacking the receptor RAGE exhibited normal uptake of ELDL and foam cell formation as shown in Figure 3G and 3H. These results collectively suggest that receptor-mediated endocytosis is not critically involved in the uptake of ELDL in SMC.
Next, we examined whether ELDL uptake by SMC depends on lipid raft or caveolins. Caveolae are specialized membrane lipid rafts enriched with the protein, caveolin-1, and caveolae contributes to a type of clathrin-independent endocytosis. 43 We used filipin, a polyene antibiotic and a selective inhibitor of lipid raft-/caveolae-mediated endocytosis. 43 Aortic SMC were incubated in medium containing 5 μmol/L filipin for 1 hour followed by incubation with ELDL for 24 hours. Filipin treatment did not attenuate ELDL-induced SMC foam cell formation ( Figure 4B and quantified in Figure 4D ). Control experiments in WT SMC using cholera-toxin B sub unit, a selective caveolae-dependent endocytic marker, 43 showed filipin inhibiting the uptake of Alexa Fluor-labeled cholera-toxin B sub unit ( Figure VI in the online-only Data Supplement). In summary, our results suggest that ELDL endocytosis in aortic SMC is not lipid raft or caveolae dependent.
We then focused on macropinocytosis, a process by which bulk cargo such as dissolved molecules and large volumes of extracellular fluid find their way into the cell in discrete vacuoles called macropinosomes. 45 The Na + /H + exchange inhibitors amiloride and its derivative 5-(N-ethyl-Nisopropyl) amiloride are classical inhibitors of macropinocytosis. 43 Importantly, amiloride at 3 mmol/L in the media for 1 hour before incubating with ELDL abolished lipid uptake and foam cell formation in WT SMC ( Figure 4C and quantified in Figure 4D ). For control experiments, we used high molecular weight dextrans which were previously shown to be taken up by macropinocytosis. 45 WT SMCs preincubated for 1 hour with amiloride at 3 mmol/L inhibited the uptake of FITClabeled dextran as shown in Figure VII in the online-only Data Supplement. In addition, fluorescently labeled latex beads (30 nm) were used as cargo for macropinocytic uptake, because latex beads sized <100 nm have been previously identified as specific macropinocytic markers. 45 WT SMCs preincubated for 1 hour with amiloride at 3 mmol/L also inhibited the uptake of fluorescently labeled latex beads ( Figure VII . Enzyme-modified nonoxidized low-density lipoprotein (ELDL) endocytosis by aortic smooth muscle cell (SMC) is mediated by macropinocytosis and is not receptor/clathrin mediated or lipid raft/caveolae dependent. A, Foam cell formation assessed by Oil red O staining in aortic SMC incubated for 24 hours with 10 μg/mL ELDL (positive control) or native LDL as negative control. Before incubation with lipoproteins, cells were pretreated for 1 hour with inhibitors of receptor-mediated endocytosis (100 μmol/L dynasore or 0.1 mol/L sucrose). Pharmacological inhibitors were not removed from media until end of experiment. B, Aortic SMC preincubated for 1 hour in serum-free medium with 5 μmol/L filipin to inhibit lipid raft-/caveolae-mediated endocytosis followed by incubation with 10 μg/mL ELDL or native LDL for 24 hours. C, Aortic SMC were preincubated for 1 hour with 3 mmol/L amiloride to inhibit macropinocytosis, followed by incubation with 10 μg/mL ELDL or native LDL for 24 hours (amiloride was not removed from the media before adding ELDL). D, Total cellular cholesterol/protein from experiments shown in A, B, and C. Data are represented as mean±SD (**P<0.01 ELDL untreated vs ELDL amiloride treated). ** that ELDL uptake by SMCs is through a mechanism involving macropinocytosis.
Phosphoinositide-Independent Macropinocytotic Uptake of ELDL in WT SMC
Macropinosomes are derived from the F-actin-driven ruffles on the cell surface that forms into a cup fusing to engulf a volume of surrounding medium and this process is regulated by the phosphoinositide phosphatidylinositol 3,4,5-trisphosphate (PIP3). The role of PIP3 in macropinocytosis has been increasingly elaborated in recent times. 46, 47 PIP3 is produced when phosphatidylinositol 4,5-bisphosphate (PIP2) is phosphorylated at the third carbon of inositol group by PI3 kinase (PI3K). The conversion of phosphatidylinositol 4,5-bisphosphate to PIP3 by PI3K promotes proper closure of nascent macropinosomes and their subsequent trafficking. Macropinocytic membrane is highly enriched in PIP3; however, exact mechanism by which PIP3 participates in macropinocytosis is still unknown. 46 Pharmacological inhibitors of PI3K (wortmannin and LY294002) are known inhibitors of macropinocytosis, and LY294002 has been previously shown to inhibit macropinocytosis in cells including macrophages at concentrations <50 μmol/L. 43 To further explore the role of macropinocytosis in the uptake of ELDL by SMC, we incubated WT aortic SMC with wortmannin or LY294002 at different concentrations for 1 hour followed by ELDL for 24 hour. When treated with 50 to 200 μmol/L LY294002, we found an ≈50% reduction in foam cell formation in WT SMC, whereas at 300 μmol/L, LY294002 ELDL uptake and foam cell formation was completely inhibited ( Figure 5A and quantified in Figure 5A ). Cell viability was not affected by treatment with LY294002 at any of the tested doses. Furthermore, wortmannin, a potent inhibitor of PI3K and previously shown to inhibit macropinocytosis in vitro at concentrations <0.2 μmol/L, 43 reduced ELDL-mediated foam cell formation of SMC at concentrations of 2 μmol/L ( Figure 5A and quantified in Figure 5C ). Concentrations of wortmannin >2 μmol/L caused significant cell death in aortic SMC (data not shown). Taken together, complete inhibition of ELDL uptake and foam cell formation in SMC requires high concentrations of the PI3K inhibitors, whereas LY294002 (50 μmol/L) and wortmannin (1 μmol/L) readily inhibited the uptake of dextran (500 KD) and latex beads (30 nm) in WT SMC (data not shown). This suggests that PIP3 only partially regulates ELDL uptake in SMC's; however, true involvement of PI3K in macropinocytosis of ELDL or the possibility of off target effects of the inhibitors in SMC cannot be excluded. As shown in Figure 3G and 3H, foam cell formation in response to ELDL is preserved in RAGE-deficient SMC suggesting that RAGE is not required for uptake of ELDL. We next examined the effects of PI3K inhibitors on foam cell formation in RAGE −/− SMC and found that RAGE −/− SMC are more sensitive to LY294002 and wortmannin than WT cells. Both inhibitors, at a concentration that were only partially effective in WT cells (50%), completely suppressed ELDL uptake and foam cell formation in RAGE −/− SMC ( Figure 5B and quantified in Figure 5C ). This suggests that RAGE modulates PI3K activity. It was previously reported that RAGE signaling downregulates Akt. 48 Therefore, we queried whether ELDL-RAGE interaction downregulates PIP3 levels. We found reduced pAkt (pAkt Ser 473) formation, suggesting reduced PIP3 levels in WT SMC, but not in RAGE −/− SMC on stimulation with ELDL. Baseline pAkt Ser 473 did not differ between SMC with intact or absent RAGE ( Figure VIII in the online-only Data Supplement). Taken together, our results suggest that ELDL is taken up by macropinocytosis in WT SMC through non-PIP3-dependent mechanisms. Apparently, ELDL-RAGE axis suppresses PIP3 activity in WT SMC and also activates the non-PIP3-dependent macropinocytosis of ELDL. In the absence of RAGE, PIP3-mediated macropinocytosis seems to be a major determinant of ELDL uptake in RAGE −/− SMC.
Macropinocytotic Uptake of ELDL by SMC: A Role for Reactive Oxygen Species and Intracellular Calcium
In view of the differential sensitivity of WT and RAGE −/− SMCs to PI3K inhibitors, we examined other features of macropinocytosis that could be regulated by RAGE. RAGE activation has been shown to upregulate cellular levels of both calcium and reactive oxygen species (ROS). 49, 50 ROS and calcium positively regulate the intracellular levels of each other as there is considerable cellular cross talk between them. 51 ROS has not been directly implicated in macropinocytosis unlike calcium which is known to regulate macropinocytosis, 45 ,52 therefore we analyzed both intracellular calcium and ROS in ELDL-treated SMC. We incubated ELDL (10 μg/ mL) with WT and RAGE −/− SMC and analyzed intracellular ROS by live cell imaging using 2′,7′-dichlorodihydrofluorescein diacetate at various time points for 24 hours. We found that ROS in WT SMC treated with ELDL steadily increased until 4 hours and then declined. Conversely, RAGE −/− SMC showed no increase in ROS production throughout the experimental period ( Figure 6A and quantified in Figure 6C ). These results indicate that ELDL-RAGE interaction is involved in the upregulation of ROS in WT cells. We next analyzed intracellular calcium on incubation with ELDL in WT and RAGE −/− SMC by live cell imaging using Fluo-8 AM at various time points for 24 hours. In response to ELDL, WT SMC calcium peaked at 6 hours and then declined, whereas in RAGE −/− SMC, the intracellular calcium remained at baseline ( Figure 6B and quantified in Figure 6D ). The increase in calcium levels in WT SMC on stimulation with ELDL was associated positively with increased cytosolic peroxide production as shown in Figure 6A and quantified in Figure 6C . In contrast, RAGE −/− SMC did not show increased calcium or H 2 O 2 production on stimulation with ELDL, suggesting that ELDL-RAGE signaling regulates ROS and calcium levels in a coordinated manner. In addition, we found that amiloride, a known inhibitor of macropinocytosis 43 which completely inhibited uptake of ELDL in WT SMC ( Figure 4C ), prevented calcium upregulation in WT SMC after 6 hours of incubation with ELDL ( Figure 6B and 6D) . This strongly suggests that calcium upregulation in cells is associated with macropinocytosis-mediated uptake of ELDL in SMC. Finally, we queried whether reducing of cytosolic calcium could block ELDL macropinocytosis in SMC. We incubated ELDL with WT and RAGE −/− SMC pretreated with the calcium channel blocker lacidipine (30 μmol/L for 1 hour) and analyzed foam cell formation after 4 and 24 hours. ELDL-mediated foam cell formation was significantly blocked at 4 and 24 hours in WT, and in RAGE −/− SMC at 4 hour, on pretreatment with lacidipine ( Figure 6E and quantified in Figure 6F ). Taken together, our data shows that ELDL macropinocytosis in SMC is mostly a function of increased cytosolic calcium that is regulated, at least in part, by interaction of ELDL with RAGE as schematically summarized in Figure 6G . However, because calcium is known to regulate cytosolic ROS levels and vice versa, 51 it is uncertain whether ELDL macropinocytosis in SMC is primarily regulated by cytosolic calcium-or ROS-dependent mechanisms.
Discussion
Early atherogenesis is characterized by the accumulation of intimal foam cells, which are often thought to be derived from the inflowing blood monocytes that differentiate into macrophages. But intimal foam cells may also be derived from SMC. The studies reported in this article have focused exclusively on cultured primary murine SMC which become foam cells in response to enzyme-modified lipoproteins, such as ELDL. We suspect that these mechanisms may also be operative in vivo.
The contribution of SMC to foam cells of the atheromatous plaque has been subject of recent studies. Identification of lesional SMC-derived foam cell is problematic because lipid-loaded SMC assume aspects of macrophage-like cells. Even an excellent recent review did not seem to resolve this issue because of the difficulty of positively identifying the cell of origin of foam cells. 53 However, with the markers, miRNA 143/145 and myocardin, Vengrenyuk et al 13 were able to indicate that SMCs probably account for ≈40% of the foam cells in mature plaques. This is consistent with relative contribution suggested by Allahverdian et al. 10 Given the likely importance of SMC foam cell formation in vivo, we have here used culture experiments to explore how such foam cell formation may occur. We show that at low concentration, LDL modified by proteolytic and esterolytic enzymes (ELDL) is able to induce SMC foam cells, a response not seen in SMC with LDL, AcLDL, or OxLDL, the latter 2 being modified LDLs readily taken up by macrophages via scavenger receptors. The enzymes used for the production of ELDL are trypsin and cholesterol esterase. Trypsin here is a model protease. If this process occurs in vivo, plasmin and metalloprotease, which have been detected in the vessel wall, are much more likely to be the operative enzymes. Cathepsins and chymase are also possible candidates. There are several Figure 6 . Macropinocytotic uptake of enzyme-modified nonoxidized low-density lipoprotein (ELDL) by smooth muscle cell (SMC): role for reactive oxygen species (ROS) and intracellular calcium. A, wild-type (WT) and receptor for advanced glycation end product (RAGE −/− ) SMC were incubated with 10 μg/mL ELDL, and ROS expression was analyzed in live cells by staining with 2′,7′-dichlorodihydrofluorescein diacetate at time points as indicated. B, WT and RAGE −/− SMC were incubated with 10 μg/mL ELDL and cytosolic calcium was analyzed in live cells by staining with Fluo-8 AM at time points as indicated. WT SMC were also pretreated with amiloride for 1 hour before adding ELDL (amiloride was not removed before the addition of ELDL). C, D, Fluorescence intensity from A and B quantified using Image J. Data are represented as mean±SD. E, WT and RAGE −/− SMC were incubated with 10 μg/mL ELDL after pretreated for 1 hour with the calcium channel inhibitor lacidipine (30 μmol/L). 54 which has cholesterol esterolytic activity, and cholesterol ester lipase secreted by endothelial cells stimulated by OxLDL. 55 In addition, Maxfield and colleagues 56 have demonstrated that an extracellular acid compartment allows for the hydrolysis of aggregated LDL by macrophages using enzymes derived from lysosomes. These compartments are apparently dynamic allowing the release of some or all of their components, including esterase, protease, and partially hydrolyzed LDL, that could provide the modified LDL similar to that studied here. That ELDL may be demonstrated in lesions was suggested by Torzewski et al 22 who raised monoclonal antibodies that react only with proteolysed apo B. This antibody recognized products in the vicinity of SMC in human coronary arteries.
When comparing aortic SMC and peritoneal macrophages, we found that ELDL uptake by SMC was not through mechanisms involving scavenger receptors in contrast to the typical scavenger receptor-mediated uptake of modified LDL by macrophages. Although, LOX-1, a major macrophage scavenger receptor for OxLDL was significantly upregulated in SMC treated with ELDL, it was not obligatorily required for ELDL uptake by the SMC. Normal SMC has low abundance of receptors for OxLDL. 57, 58 Interestingly, it was reported that only intimal SMC isolated from lesions but not medial SMC showed scavenger receptor activity 58, 59 suggesting that scavenger receptor activity of intimal SMC might stem from local factors within the lesions. The causative factors are currently unknown, and our data suggest that ELDL could potentially mediate the increased expression of at least one scavenger receptor.
A primary conclusion of our study is that ELDL uptake by SMC occurs via macropinocytosis. Specific inhibitors have been used to show that receptor-mediated endocytosis and caveolar function are not required for ELDL uptake. Also the concentration dependence of ELDL uptake is consistent with a fluid phase mechanism, such as macropinocytosis. Macropinocytosis has been well established to account for the uptake of normal LDL by macrophages 60 which we have shown in this study to also occur in aortic SMC. But higher concentrations (>2 mg/mL) of normal LDL are required for these pathways than is required for the uptake of ELDL by SMC, for which concentrations as low as 10 μg/mL are sufficient. However, limitations of our study is the use of pharmacological inhibitors to various forms of ELDL uptake, and as with all experiments using pharmacological compounds, off target effects, known or unknown, cannot be excluded. Moreover, other potential mechanisms operating in SMC for the uptake of ELDL such as patocytosis, which was suggested as a mechanism for ELDL uptake in macrophages by Kruth et al, 61 cannot be excluded because specific inhibitors of patocytosis are not available.
Our knowledge of macropinocytosis mechanisms is evolving. Calcium is suggested to be an inducer of macropinocytosis. 45, 52 In our studies, calcium channel blocker lacidipine abolished ELDL uptake in the WT SMC. Lacidipine (compared with atenolol) was previously shown to decrease an carotid artery atherosclerosis in the European Lacidipine Study on Atherosclerosis with a greater efficiency on carotid intima-media thickness and number of plaques per patient, despite a smaller reduction in ambulatory blood pressure. This suggests an antiatherogenic action of lacidipine independent of its antihypertensive action. 62 Inhibition of ELDL-induced SMC foam cells could be one reason for the reduced intimamedia thickness and carotid atherosclerosis observed in this clinical trial with lacidipine.
RAGE is not required for the uptake of ELDL. However, RAGE does seem to influence some of the signals that participate in the regulation of factors thought to be involved in the macropinocytosis pathway. This is schematized in Figure 6G . PIP3 is known to be involved in macropinocytosis, 46, 47, 63 but like RAGE, it is apparently not obligatory for ELDL macropinocytosis. We demonstrate that pharmacological inhibition of PI3K, the enzyme responsible for PIP3 formation, was partially effective in preventing the uptake of ELDL in WT SMC. On the other hand, ELDL uptake was abolished by PI3K inhibitors in RAGE-deficient SMC, suggesting that RAGE regulates PI3K and PIP3 levels. PIP3 has pleiotropic functions beyond regulating macropinocytosis. For example, PIP3 is an important plasma membrane phospholipid that is involved in the phosphorylation and activation of Akt. 64 RAGE signaling has been shown to activate PI3K/PIP3/Akt pathway in some studies, 65, 66 whereas other studies have shown RAGE inactivating Akt. 48, 67 Apparently, different ligands activate RAGE differently with regard to its downstream Akt activation. In our studies, ELDL uptake by WT SMC downregulates phosphorylated Akt (pAkt Ser473) similar to that by LY294002 (PI3K inhibitor), but does not downregulate Akt in RAGE −/− SMC. Experiments with SMC pretreated with 2 μmol/L triciribine, a global inhibitor of Akt, indicated that Akt activity was not required for the normal uptake of ELDL and foam cell formation ( Figure IX in the online-only Data Supplement). It is clear that the relationship between macropinocytosis of ELDL by SMC and RAGE influence on the PI3K/PIP3/Akt axis is a complex one that will depend on further exploration for clarification.
Although RAGE is not required for the macropinocytosis of ELDL, RAGE modifies the cellular responses to ELDL. We showed that upregulation of LOX-1 and uptake of oxLDL is primed by ELDL in a RAGE-dependent manner in SMC. RAGE is a multiligand receptor with a propensity for increased binding affinity for several ligands that oligomerize. 40 ELDL particles consist of fused and larger LDLs and may therefore Figure 6 Continued. PIP3 by PI3 kinase (PI3K), and blocking PIP3 formation with PI3K inhibitors (LY294002, wortmannin) are known strategies to impair macropinocytosis. PI3K inhibitors partially prevented macropinocytosis of ELDL in SMC in contrast to the complete inhibition of macropinocytosis of ELDL in SMC deficient for RAGE treated with the PI3K inhibitors. ELDL-RAGE signaling down regulates PIP3; nevertheless, ROS and cellular Ca 2+ levels are upregulated by ELDL in the SMC. Ca 2+ is also an important determinant of macropinocytosis whose mechanism of action is unknown. Despite PIP3 inhibition by ELDL, we see unhindered macropinocytosis of ELDL, which suggests elevated cellular Ca 2+ is potent enough to override the inhibition of PIP3 by ELDL via some unknown mechanisms.
bind and activate RAGE similar to what was previously shown for OxLDL. 68 Although OxLDL binds RAGE on account of its AGE epitopes, ELDL differs significantly from OxLDL 21 and it is not known whether ELDL has AGE epitopes. Given the mechanisms here explored, we can conclude that RAGE is not functioning as an endocytic receptor for ELDL uptake, but rather influences uptake as a cell surface signaling molecule. RAGE is strongly implicated in the pathology of atherosclerosis. Studies with Apoe, Rage-double knockout mice had shown significant protection from high-fat diet-induced atherosclerosis 41, 69 and diabetes mellitus-induced atherosclerosis. 70 Our data suggest that impaired intimal SMC foam cell formation could be one underlying mechanism for the reduced atherosclerosis seen in Rage null/Apoe null mice. In view of the complex interaction between macropinocytosis and RAGE participation, one possibility that should be entertained is that there are 2 pathways for the macropinocytosis of ELDL, one of which is influenced by RAGE. For example in the macropinocytosis of normal LDL by macrophages, Kruth et al 60 have suggested that this may be by either a microtubule dependent or independent pathway.
In summary, there is compelling in vitro evidence that ELDL, of the modified LDLs studied, is the preferred cholesterol-containing particle taken up by SMC causing formation of foam cells. Whether ELDL induces the same changes in intimal SMC in vivo, and thereby possibly accelerates atherosclerosis, is not known. Conditional knockouts of gene participants in the pathways here described could provide further insight on the contribution of each of these cells. A better understanding of these processes may lead to potential therapeutic options to inhibit ELDL uptake and smooth muscle foam cell formation.
